MAKRIYANNIS ALEXANDROS has a total of 18 patent applications. Its first patent ever was published in 1999. It filed its patents most often in United States, WIPO (World Intellectual Property Organization) and Australia. Its main competitors in its focus markets organic fine chemistry, pharmaceuticals and measurement are ANTIBE HOLDINGS INC, DOMPE SPA and JOUVEINAL INST RECH.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 12 | |
#2 | WIPO (World Intellectual Property Organization) | 4 | |
#3 | Australia | 2 |
# | Industry | |
---|---|---|
#1 | Organic fine chemistry | |
#2 | Pharmaceuticals | |
#3 | Measurement |
# | Name | Total Patents |
---|---|---|
#1 | Makriyannis Alexandros | 18 |
#2 | Vemuri Venkata Kiran Rao | 4 |
#3 | Thotapally Rajesh | 4 |
#4 | Olszewska Teresa | 4 |
#5 | Piomelli Daniele | 2 |
#6 | Vemuri Venkata K | 2 |
#7 | Lin Sonyuan | 2 |
#8 | Goutopoulos Andreas | 2 |
#9 | Vemuri Venkata Kiran | 2 |
#10 | Nikas Spyridon P | 2 |
Publication | Filing date | Title |
---|---|---|
US2012046280A1 | Heteropyrrole analogs acting on cannabinoid receptors | |
WO2008154015A1 | Cb1 receptor antagonists and uses thereof | |
US2009306016A1 | Fatty acid amide hydrolase inhibitors | |
US2007155701A1 | Keto cannabinoids with therapeutic indications | |
US2010063050A1 | Heteropyrrole analogs acting on cannabinoid receptors | |
US2006100208A1 | Pyrazole derivatives as cannabinoid receptor antagonists | |
AU2003285071A8 | Antiprotozoal ring-substituted phospholipids | |
WO0032200A1 | Cannabimimetic lipid amides as useful medications | |
US7897598B2 | Inhibitors of the anandamide transporter |